

Microneedle Patch: A Pain-Free Alternative for Long-Term Treatment
Millions of patients with neurological and chronic diseases depend on regular drug injections to manage their conditions. However, repeated needle use often causes discomfort, fear, and reduced treatment compliance. Researchers from Chung-Ang University, South Korea, have developed a new bee-sting-inspired microneedle patch designed to deliver medication painlessly and effectively over extended periods.
Unlike traditional microneedles, which are rigid and may irritate the skin, these Electrospun Web Microneedles (EW-MNs) are soft, breathable, and designed to stay securely in place, much like a bee stinger. This innovation offers a patient-friendly solution for continuous drug delivery without the anxiety associated with conventional needle injections.
Explore All Neurology CME/CE Conferences and Online Courses
How EW-Microneedles Work: Inspired by Nature
The research team, led by Professor Wonku Kang and Dr. Sohee Jeon, created the microneedles using electrospinning technology, which forms nanoscale fibers around the needle tips. This structure mimics the natural barbed design of a bee stinger, allowing the microneedles to anchor gently yet firmly into the skin.
The EW-MNs are mounted on an adhesive patch, enabling controlled drug release over a wider area with minimal discomfort. In preclinical tests using guinea pigs, the patches were loaded with rivastigmine, a medication commonly used for Alzheimer’s and Parkinson’s disease. Results showed a two-fold increase in drug absorption and coverage of five times the skin area compared to traditional delivery methods.
Even when minor irritation occurred, it resolved quickly after the patch was removed, demonstrating the system’s potential for safe, long-term use.
“With further development, these EW-MNs could transform drug delivery, allowing patients to receive effective long-term treatments without the fear or discomfort of needles,” said Prof. Kang.
Future Potential Beyond Neurological Disorders
The EW-MN patch system has applications far beyond neurological diseases. The researchers envision its use for a range of chronic illnesses, offering a practical option for elderly patients, children, and individuals requiring safe, self-administered treatments.
This breakthrough represents a promising step toward needle-free drug delivery, potentially improving adherence, reducing healthcare burdens, and enhancing overall patient quality of life.
Source:
more recommended stories
AI Reshapes Anticoagulation in Atrial Fibrillation Care
Understanding the Challenge of Atrial Fibrillation.
Hemoglobin as Brain Antioxidant in Neurodegenerative Disease
Uncovering the Brain’s Own Defense Against.
Global Data Resource for Progressive MS Research (Multiple Sclerosis)
The International Progressive MS Alliance has.
AI Diabetes Risk Detection: Early T2D Prediction
A new frontier in early diabetes.
Cancer Cells Learn to Self-Report: A New Frontier in Immunotherapy
How a Drug Complex Enables Immune.
Staphylococcus Shows Complex Enzyme Redundancy, Study Finds
A Bacterial Pathogen That Refuses to.
Parkinson’s Disease Care Advances with Weekly Injectable
A new weekly injectable formulation of.
New Blood Cancer Model Unveils Drug Resistance
New Lab Model Reveals Gene Mutation.
Osteoarthritis Genetics Study Uncovers New Treatment Hope
Osteoarthritis- the world’s leading cause of.
Antibody Breakthrough in Whooping Cough Vaccine
Whooping cough vaccine development is entering.
Leave a Comment